Clinical Trial Update: Comparison of Two Doses of Carbetocin for Prevention of Uterine Atony, During Elective Cesarean Section [Phase 4]

View source ↗

Summary

A Phase 4 trial compared two doses of carbetocin for prevention of uterine atony during elective cesarean section. The study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postpartum Hemorrhage
• Uterine Atony

Drugs mentioned

• Carbetocin (carbetocin)

Snippet

Sponsor: Laval University | Conditions: Uterine Atony, Post-partum Hemorrhage | Phase 4 | Status: COMPLETED